California State Teachers Retirement System raised its position in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 19.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 71,385 shares of the company’s stock after purchasing an additional 11,555 shares during the quarter. California State Teachers Retirement System’s holdings in Cellebrite DI were worth $1,573,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently made changes to their positions in the company. Gen Wealth Partners Inc acquired a new stake in Cellebrite DI in the 4th quarter valued at approximately $85,000. NewEdge Advisors LLC grew its holdings in Cellebrite DI by 600.7% during the fourth quarter. NewEdge Advisors LLC now owns 3,910 shares of the company’s stock worth $86,000 after acquiring an additional 3,352 shares during the period. Polen Capital Management LLC acquired a new position in Cellebrite DI during the fourth quarter worth about $222,000. Victory Capital Management Inc. acquired a new position in shares of Cellebrite DI in the 4th quarter worth approximately $234,000. Finally, HighTower Advisors LLC acquired a new position in shares of Cellebrite DI in the 4th quarter worth approximately $274,000. Institutional investors and hedge funds own 45.88% of the company’s stock.
Cellebrite DI Stock Performance
CLBT opened at $16.53 on Monday. The company has a market cap of $3.96 billion, a PE ratio of -11.89, a price-to-earnings-growth ratio of 4.27 and a beta of 1.32. The stock has a 50-day moving average of $18.36 and a 200-day moving average of $20.08. Cellebrite DI Ltd. has a 52-week low of $10.55 and a 52-week high of $26.30.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on the company. Lake Street Capital boosted their target price on Cellebrite DI from $17.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday, February 14th. JPMorgan Chase & Co. dropped their price target on Cellebrite DI from $29.00 to $25.00 and set an “overweight” rating on the stock in a research note on Monday, May 12th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $24.00 price target on shares of Cellebrite DI in a research note on Friday. Seven equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $22.43.
Read Our Latest Analysis on CLBT
Cellebrite DI Company Profile
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.
Further Reading
- Five stocks we like better than Cellebrite DI
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Five Below Pops on Strong Earnings, But Rally May Stall
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Intel’s Dual Gamble: AI Innovation Now, Foundry Fortunes Later?
- What Are Dividend Contenders? Investing in Dividend Contenders
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
Want to see what other hedge funds are holding CLBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report).
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.